Dexcom
DXCM · NASDAQ · USD · Healthcare
1What is happening
Dexcom has fallen 12% since its 6-week high on 05/11/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-12.0%
Other view · 26 analystsHorizon: 12 months26 Buy · 3 Hold · 0 Sell2Our assessment
Dip in progress46How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-12.0%
Highest daily price: $90.25 on 05/11/2026 · reference of the assessment
- from the 3-month high-14.2%
Highest daily price in 3 months: $92.59 on 24/08/2026
- from the 52-week high-14.2%
Highest price in 52 weeks: $92.59 (Yahoo)
Why is it down?
market-wide- ·From its 6-week high of $90.25 on 05/11/2026 the price fell 12.0% to $79.41.
- ·The biggest single-day drop was 6.4% on 21/10/2026.
- ·No clear news driver in the last 10 days.
- ·The whole market is down 5.6% from its 60-day high, so part of this is not about the company.
- ·Other Medical Devices stocks we track are down only 5.4% on average, so this is mostly about the company. See all 77 in this sector →
Market-wide drops tend to recover together with the market. The dip score looks at the company on top of that.
What analysts expect
Most of the 26 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 2690 %
- Hold
- 310 %
- Sell
- 00 %
Average price target$98.15
$79.00 to $120.00 · today $79.41
$79.00Ø $98.15$120.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
The company in figures
- Market value
- 29.6 bn $
- All shares together at the current price.
- P/E
- 31.3
- Price divided by earnings per share, last 12 months.
- 52-week range
- $54.20 – $92.59
- Lowest and highest price of the last year.
Catalysts
36 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 29/10/2026 +8.3% vs estimate
Key figures
- Market value
- 29.6 bn $Large cap
- P/E
- 31.3
- Volume today
- 0.9 × Øabout usual
- Beta
- 1.44swings more than the market
- 52-week range
- $54.20 – $92.59price at 66 % of the range
About Dexcom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
- Headquarters:
- San Diego, United States
- 52-week range:
- $54.20 – $92.59
- Website:
- dexcom.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.